9 Recruiting HIV-1-infection Phase 3 Clinical Trials
Active phase 3 studies for hiv-1-infection enrolling across the USA. Verify eligibility and contact site coordinators.
All HIV-1-infection studiesPhase 3 Studies for HIV-1-infection
🔵 Active, Not Recruiting Phase2 / Phase3
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
📍 Be Well Medical Center — Berkeley, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
📍 UAB 1917 Research Clinic — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
📍 Pueblo Family Physicians — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
📍 University of Alabama at Birmingham(UAB) 1917 Research Clinic — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
📍 Ruane Clinical Research Group Inc — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
📍 Be Well Medical Center — Berkeley, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
📍 Midway Immunology and Research Center — Ft. Pierce, Florida
View Study & Checklist ➔